Proposed federal budget would limit access to student loans
Students take photos in their caps and gowns at Columbia University in New York City on April 26, 2024. File Photo by John Angelillo/UPI | License Photo
June 28 (UPI) -- The latest version of the Senate's federal budget reconciliation bill would limit the availability of student loans for future borrowers by revising federal student loan programs and regulations.
The budget bill that already has passed the House of Representatives and the Senate version would place a maximum amount on how much people could borrow through the federal Parent PLUS and graduate student loans to help them pay for their college educations.
The House-approved version would limit undergraduate borrowing to $50,000, while the Senate version would limit that amount to $65,000.
Graduate students would see limits of $100,000 for most master's programs, while the borrowing limit for professional degrees would be $150,000 in the House version and $200,000 in the Senate bill.
Supporters of the proposed limits say they could save taxpayers more than $300 billion and make it harder for college and university administrators to raise tuition costs and fees.
Opponents say it would make it harder for disadvantaged students to attend college.
"It's abundantly clear that the budget reconciliation package would reduce access to higher education and healthcare and jeopardize [the University of California's] ability to carry out its public service mission," Chris Harrington, U.C. associate vice president for Federal Governmental Relations, said on Monday in a letter to the state's House delegation in May.
The House-approved bill would eliminate Pell Grants for part-time students, subsidized loans for undergrads and Graduate PLUS loans for graduate and professional students, according to the University of California.
It also would limit eligibility for Supplemental Nutrition Assistance Program and Medicaid benefits for low-income students.
The Senate's version of the proposed fiscal year 2026 budget reconciliation bill numbers 940 pages and might be voted on as soon as Saturday night.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
9 minutes ago
- Axios
Gen Z and millennials push into politics
A growing number of Gen Z and millennial Americans are seeking elected office — campaigning on the issues that matter most to them and their peers. Why it matters: The 119th Congress is the third oldest in U.S. history, and both of America's most recent presidents set records as the oldest ever inaugurated. As leadership skews older, young candidates from both parties are running to get their voices heard in local, state and federal government. The big picture: 74 millennials and one Gen Z-er were elected to the 119th Congress in November — making up 16% of the House and 8% of the Senate. Members of Gen Z also entered state and local office races. Case in point: Thousands of young progressives have expressed interest in running for office since Zohran Mamdani 's New York City mayoral primary last week. Between Tuesday's primary and Friday afternoon, about 2,700 people signed up with Run for Something, an organization that supports young Democrats running for down-ballot office. Mamdani's race modeled "what will make young people such compelling candidates in the future," says Amanda Litman, Run for Something co-founder and president. "A real fluency with the internet, a real strong-held value system, the ability to be authentically themselves." Zoom in: If elected in November, 33-year-old Mamdani would be the youngest among the mayors currently serving in the 50 largest American cities, according to an Axios analysis. He'd also be New York City's second-youngest mayor, after Hugh J. Grant in the late 19th century. His campaign — built more for TikTok than TV — resonated with young voters around the city and brought them to the polls. The other side: Run Gen Z, an organization that backs young conservatives running for office, is galvanizing the next generation of leaders on the right. The group has helped politicians like 22-year-old Wyatt Gable, who was elected to North Carolina's House of Representatives in November, and 26-year-old Amber Hulse, who just won a seat in South Dakota's senate. Gable told the Washington Post one of his priorities is implementing home economics education for high school students so they can graduate with practical skills, like financial literacy. The intrigue: Candidate age is becoming an increasingly important issue for American voters. 67% of U.S. adults in a February YouGov poll said they believed maximum age limits should be imposed on elected officials. Democratic respondents were more likely than Republicans to support age limits. Reality check: Americans 62 and older still run for office at much higher rates than 18- to 25-year-olds, Tufts' Center for Information and Research on Civic Learning and Engagement notes.
Politico
23 minutes ago
- Politico
Warner predicts Trump's "Big Beautiful Bill" will cripple GOP support
Senate Republicans released updated megabill text late Friday that would make sharp cuts to the Inflation Reduction Act's solar and wind tax credits after a late-stage push by President Donald Trump to crack down further on the incentives. The text would require solar and wind generation projects seeking to qualify for the law's clean electricity production and investment tax credits to be placed in service by the end of 2027 — significantly more restrictive than an earlier proposal by the Senate Finance Committee that tied eligibility to when a project begins construction. The changes came after Trump urged Senate Majority Leader John Thune to crack down on the wind and solar credits and align the measure more closely with reconciliation text, H.R.1, that passed the House, as POLITICO reported earlier on Friday. The changes are likely to put some moderate GOP senators, who have backed a slower schedule for sunsetting those incentives, in a tough position. They'll be forced to choose between rejecting Trump's agenda or allowing the gutting of tax credits that could lead to canceled projects and job losses in their states — something renewable energy advocates are also warning about. 'We are literally going to have not enough electricity because Trump is killing solar. It's that serious,' Sen. Brian Schatz (D-Hawaii) responded on X early Saturday. 'We need a bunch of new power on the grid, and nothing is as available as solar. Everything else takes a while. Meantime, expect shortages and high prices. Stupid.' The revised text would retain the investment and production tax credits for baseload sources, such as nuclear, geothermal, hydropower or energy storage, as proposed in the Finance Committee's earlier proposal. But it would make other significant changes, including extending a tax credit for clean hydrogen production until 2028. The panel's earlier proposal would have eliminated the credit after this year. And despite vocal lobbying by the solar industry, the proposal would maintain an abrupt cut to the tax incentive supporting residential solar power. The committee's earlier proposal would have eliminated that credit six months after the enactment of the bill; now the updated draft proposes repealing it at the end of this year. It would also deny certain wind and solar leasing arrangements from accessing the climate law's clean electricity investment and production tax credits, but, in a notable change, removed earlier language specifically disallowing rooftop solar. And it would move up the timeline for certain rules barring foreign entities of concern from accessing those credits. The bill would move up the termination date for electric vehicle tax credits to Sept. 30, compared to six months after enactment in the earlier Finance text. The credit for EV chargers would extend through June 2026. The new text also provides a bonus incentive for advanced nuclear facilities built in communities with high levels of employment in the nuclear industry. And the bill makes metallurgical coal eligible for the advanced manufacturing production tax credit through 2029. Sam Ricketts, co-founder of S2 Strategies, a clean energy policy consulting group, said the new draft is going to 'screw' ratepayers, kill jobs and undermine U.S. economic competitiveness. 'All just to give fossil fuel executives more profits,' he said. 'Or to own the libs. Insanity.' Josh Siegel contributed to this report.
Politico
27 minutes ago
- Politico
RFK Jr. is bringing psychedelics to the Republican party
Driven by a desire to help ex-servicemembers with mental illness, GOP lawmakers led a failed campaign last year to persuade the Biden administration to approve psychedelic drugs. Now they may have found the ally they need in President Donald Trump's health secretary, Robert F. Kennedy Jr. A longtime believer in psychedelics' potential to help people with illnesses like post-traumatic stress disorder and depression, despite the lack of supportive evidence Biden officials found, Kennedy is ramping up government-run clinical studies and telling the disappointed lawmakers doctors will be prescribing the drugs soon. 'These are people who badly need some kind of therapy, nothing else is working for them,' Kennedy said at a House hearing Tuesday. 'This line of therapeutics has tremendous advantage if given in a clinical setting. And we are working very hard to make sure that that happens within 12 months.' The GOP's embrace of psychedelics is another, and perhaps one of the more jarring, examples of cultural transformation that Trump's populist politics have brought. Veterans seeking cures for mental illnesses associated with combat, combined with the Kennedy-backed Make America Healthy Again movement's enthusiasm for natural medicine, have strengthened a libertarian strain on the right in favor of drug experimentation. Meanwhile, the left, where hippies are giving way to technocrats, has become more skeptical. When Joe Biden was president, for example, agencies studied the drugs' medical potential, but an air of doubt prevailed. The head of the National Institute on Drug Abuse, Nora Volkow, compared the hype for psychedelics as a cure for mental illness to belief in 'fairy tales' in Senate testimony last year. Then in August, the Food and Drug Administration rejected drugmaker Lykos Therapeutics' application to offer ecstasy, alongside therapy, as a treatment for PTSD. FDA advisers worried the company's researchers were more evangelists than scientists and determined that they'd failed to prove their regimen was either safe or effective. Republicans complained the loudest. 'These technocrats think they know better,' Texas GOP Rep. Dan Crenshaw, a former Navy SEAL who lost an eye in Afghanistan, wrote on X after FDA advisers recommended Lykos' application be rejected. 'Their job is to say NO and support the status quo.' But Crenshaw, who's helped secure funding for psychedelic research at the Defense Department, got the response he wanted from Kennedy at Tuesday's budget hearing. Kennedy said results from early government studies at the Department of Veterans Affairs and FDA were 'very, very encouraging.' He added that his FDA commissioner, Marty Makary, sees it the same way. 'Marty has told me that we don't want to wait two years to get this done,' he said. Crenshaw was pleased. 'I've spent years supporting clinical trials to study the use of psychedelics to treat PTSD,' he told POLITICO. 'It's been a long fight, and it's taken a lot of grit. I'm grateful Secretary Kennedy is taking this seriously — helping to mainstream what could be a groundbreaking shift in mental health.' Kennedy's comments have revived hope among psychedelics' advocates that the Lykos decision was more hiccup than death knell. 'It's important for the entire community and the entire value chain around psychedelic therapy to hear that he wants to responsibly explore the benefits and risks of these therapies,' said Dr. Shereef Elnahal, a health official at the VA under Biden who sees promise in the drugs. The VA, under Trump's secretary, Doug Collins, is working directly with Kennedy on clinical research. Collins has referenced psychedelics on a podcast appearance, on X and at a cabinet meeting this spring when Trump pressed him on what he's doing to drive down the high suicide rate among veterans. 'I talk with Collins about it all the time,' Kennedy said Tuesday. 'It's something that both of us are deeply interested in.' Earlier this month, Texas' Republican governor, Greg Abbott, signed a law to put $50 million into clinical trials of the psychedelic ibogaine, as a mental health treatment. 'That culture shift is underway,' W. Bryan Hubbard, who spearheaded the Texas bill and is executive director of the American Ibogaine Initiative, told POLITICO. As Hubbard sees it, the narrative around psychedelics has evolved from counterculture recreation to a promising medical treatment for the 'deaths of despair' from alcohol, drug overdoses and suicides the United States has grappled with in recent decades. Kennedy was happy to see it. 'It's super positive. It is really notable that the Republicans have become the party of some of these issues you wouldn't have expected before,' Calley Means, a top Kennedy adviser, told POLITICO. 'States pushing the envelope is certainly aligned with what Secretary Kennedy is trying to do. It gives him leverage to push bolder reforms.' The Texas effort involved a six-month sprint by Hubbard and former GOP Gov. Rick Perry to convince state lawmakers to pass the bill. Rep. Morgan Luttrell, another Lone Star Republican who credits ibogaine he took in Mexico with helping him overcome trauma he incurred during military service, also lobbied for it. Hubbard attributes their success partly to Texas' independent pioneer culture and a red-state philosophy that was receptive to his pitch for a medicalized psychedelics model. It didn't hurt that Abbott had signed a bill to study ecstasy, psilocybin and ketamine as treatments for veterans with PTSD with Baylor College of Medicine. And since Texans are no stranger to religion, conversations about the spiritual aspect of ibogaine treatment seemed to resonate with lawmakers. 'We had a message that was tailor-made for the Lone Star State,' he said. Veterans turned out at public hearings to describe traveling out of the country, often to Mexico, where ibogaine is unregulated, to receive treatment they couldn't access in the U.S. 'These heroes have gone to war to defend the land of the free, only to come home and be faced with inflexible, bureaucratic systems that offer ineffectual solutions, paired with the Controlled Substances Act that has forced them to flee the country that they have defended in order to access treatment in a foreign country,' Hubbard said. But the biggest momentum push was likely the boost Hubbard and Perry got from conservative kingmaker Joe Rogan when the two went on Rogan's podcast in January. 'That really put a tremendous amount of wind in our sails,' Hubbard said. Still, last year's FDA decision to reject Lykos Therapeutics' application underscores the concerns raised by many scientists that the utility of the drugs is oversold. FDA advisers raised ecstasy's potential to damage the heart and liver; a suspicion that trial researchers were more advocates than scientists; and a worry that results had been skewed by the psychedelics' pronounced effects, since participants could figure out if they got the drug. Ibogaine also poses heart risks. The Drug Enforcement Administration lists both it and ecstasy on its schedule of drugs with no currently acceptable medical use and high risk of abuse. That would have once been enough to make law-and-order Republicans say no. Kennedy's adviser Means says things are changing for the better. 'Ten years ago, nobody expected the Republican Party as the party of healthy food, as the party of exercise, as the party of questioning pharmaceutical companies, as the party of psychedelic research — but that's where we are,' Means said. 'The Democratic Party has become the party of blindly trusting experts,' he concluded. 'The Republican Party has become the countercultural party that's asking common-sense questions.'
